Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • Subscribe to Print Magazine
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

Licensing Agreement for Pharmaceutical Disposal Technology Between Teikoku Pharma USA, Inc. and Verde Environmental Technologies Inc.

September 14, 2011 By Bio-Medicine.Org

SAN JOSE, Calif., Sept. 14, 2011 /PRNewswire/ — Teikoku Pharma
USA, Inc., (“TPU”) is pleased to announce an exclusive license
agreement with Verde Environmental Technologies Inc. (“Verde”), a
company aimed at developing environmentally responsible solutions
for pharmaceutical disposal.  Verde is a privately held
company, founded by former executives of TPU and Travanti Pharma,
Inc.

Verde obtained rights to develop products, which are designed to
adsorb and inactivate the active ingredients in pills, tablets,
capsules and topical patches, in a convenient and environmentally
responsible manner, based on patented technology developed and
owned by TPU.  

“We are very pleased that these new product ideas that were
generated from our research led to this important new development,
stated TPU CEO, Masahisa Kitagawa.  TPU located in San Jose,
California is the US operations of Teikoku Seiyaku Co., Ltd., one
of the world’s largest manufacturers of medicated patches based in
Japan, and its product, Lidoderm, is a leading global brand.

“The products being developed by Verde will address the growing
issue of pharmaceutical contamination of groundwater supplies.
 By providing an effective means of adsorbing the active
ingredients, this will help keep waste pharmaceuticals from
appearing in the water supply,” stated Verde Chairman and CEO, Dr.
Andrew Korey.  “In addition, these developments will provide
anti-abuse features, and improved safety, by diminishing the risk
of accidental poisoning from active pharmaceuticals disposed in
trash.”

About Teikoku

Teikoku Pharma USA Inc., a wholly-owned subsidiary of Teikoku
Seiyaku Inc. of Japan, is a specialty pharmaceutical company that
develops, and manufactures enhanced pharmaceutical products based
on its transdermal drug delivery technologies. Teikoku focuses its
efforts in two therapeutic areas; Pain Management and CNS.
Teikoku’s main product is Lidoderm® (Lidoca

‘/>”/>

SOURCE

Related Articles Read More >

TE Connectivity opens global medical device prototyping center in Ireland
Prix Galien USA 2022 nominees
The 24 best medical device innovations of 2022
A portrait of Ellen Roche, MIT School of Engineering associate professor
New implant design prevents scar tissue without drugs, MIT says
UMN artificial blood vessel clinical trial
Minnesota researchers awarded $3.7M grant for artificial, bioengineered blood vessel clinical trial

DeviceTalks Weekly.

August 12, 2022
DTW – Medtronic’s Mauri brings years of patient care to top clinical, regulatory, scientific post
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech100 Index
  • Medical Tubing + Extrusion
  • Medical Design Sourcing
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media LLC. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • Subscribe to Print Magazine
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech